EvidentIQ

EvidentIQ, founded in 2021 and headquartered in Germany, is a next generation technology-amplified data science group that aims to set new standards in value creation and innovation. The company offers an end-to-end eClinical solution, catering to the increasing customer demand across clinical operations and clinical data management needs within a single integrated cloud platform. Through its suite of applications and a broad data science service portfolio, EvidentIQ assists customers in optimizing HTA submissions, pricing, and reimbursement needs. The company's reach extends to over 20 countries, including the US, Germany, France, the UK, Italy, Japan, and China. EvidentIQ supports 15 of the top 20 pharma companies through novel RWE solutions, and it serves 150+ SMB customers. EvidentIQ's offerings encompass a variety of services, including an in-country patient communities platform, patient recruitment, patient engagement media, and real-world evidence late phase solutions. The company also provides fast, flexible, and focused services, allowing customers to select the services they require and create an ideal mix of professional study setup, consulting, and training services. Additionally, EvidentIQ offers proprietary tools and an in-house data science team to support its projects. With its progressive approach and significant industry partnerships, EvidentIQ presents a compelling investment opportunity within the biotechnology, data analytics, and pharmaceutical sectors.